Pelthos Therapeutics (PTHS) Other Operating Expenses (2023 - 2026)
Pelthos Therapeutics (PTHS) posted quarterly Other Operating Expenses of $2.5 million for Q4 2025, down 45.03% year-over-year from $4.6 million in Q4 2024, and down 14.89% quarter-over-quarter from $3.0 million in Q3 2025.
Pelthos Therapeutics (PTHS) Other Operating Expenses (2023 - 2026) Analysis & Trends
Pelthos Therapeutics' Other Operating Expenses history runs 3 years deep, the most recent figure standing at $2.5 million for Q4 2025.
- In Q4 2025, Other Operating Expenses fell 45.03% year-over-year to $2.5 million; the TTM figure through Dec 2025 stood at $7.7 million (up 81.32% YoY), while the FY2025 annual figure was $5.5 million, changed N/A from the prior year.
- Other Operating Expenses for Q4 2025 stood at $2.5 million, down from $3.0 million in the prior quarter.
- The five-year high for Other Operating Expenses was $4.6 million in Q4 2024, with the low at -$1.6 million in Q3 2024.
- The 3-year median for Other Operating Expenses is $565326.0 (2023), against an average of $1.1 million.
- Peak annual rise in Other Operating Expenses reached 787.07% in 2024, while the deepest fall reached 377.44% in 2024.
- Pelthos Therapeutics' Other Operating Expenses stood at $522731.0 in 2023, then surged by 787.07% to $4.6 million in 2024, then plunged by 45.03% to $2.5 million in 2025.
- Business Quant data shows PTHS's Other Operating Expenses at $2.5 million in Q4 2025, $3.0 million in Q3 2025, and $1.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Pelthos Therapeutics | 91.09 Mn | 66.53 Mn | 21.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.36 Mn |
| Dec 31, 2025 | 2.55 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 1.61 Mn |
| Mar 31, 2025 | 549,630.00 |
| Dec 31, 2024 | 4.64 Mn |
| Sep 30, 2024 | -1.61 Mn |
| Jun 30, 2024 | 541,257.00 |
| Mar 31, 2024 | 679,815.00 |
| Dec 31, 2023 | 522,731.00 |
| Sep 30, 2023 | 581,022.00 |
| Jun 30, 2023 | 189,329.00 |
| Mar 31, 2023 | 250,836.00 |